BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29269725)

  • 1. Effect of Calcipotriol on IFN-γ-Induced Keratin 17 Expression in Immortalized Human Epidermal Keratinocyte Cells.
    Zhang J; Fang H; Wang R; Dang E; Jiang M; Wang G
    Med Sci Monit; 2017 Dec; 23():6049-6056. PubMed ID: 29269725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin inhibits IFN-γ-induced K17 over-expression of HaCaT cells by interfering with STAT3 signaling.
    Liu L; Wu Y; Cao K; Xu YY; Gao XH; Chen HD; Geng L
    Int J Clin Exp Pathol; 2015; 8(8):9202-7. PubMed ID: 26464667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gamma.
    Bonnekoh B; Huerkamp C; Wevers A; Geisel J; Sebök B; Bange FC; Greenhalgh DA; Böttger EC; Krieg T; Mahrle G
    J Invest Dermatol; 1995 Jan; 104(1):58-61. PubMed ID: 7528246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 Promotes Keratinocyte Proliferation in Psoriasis through Up-Regulation of Keratin 6, Keratin 16, and Keratin 17.
    Yang L; Fan X; Cui T; Dang E; Wang G
    J Invest Dermatol; 2017 Oct; 137(10):2168-2176. PubMed ID: 28576737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NB-UVB irradiation downregulates keratin-17 expression in keratinocytes by inhibiting the ERK1/2 and STAT3 signaling pathways.
    Zhuang Y; Han C; Li B; Jin L; Dang E; Fang H; Qiao H; Wang G
    Arch Dermatol Res; 2018 Mar; 310(2):147-156. PubMed ID: 29349514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2.
    Zhang W; Dang E; Shi X; Jin L; Feng Z; Hu L; Wu Y; Wang G
    PLoS One; 2012; 7(7):e40797. PubMed ID: 22808266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy with 5-aminolevulinic acid suppresses IFN-γ-induced K17 expression in HaCaT cells via MAPK pathway.
    Wang XL; Sun Q
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4694-4702. PubMed ID: 29131243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis.
    Chang T; Sun L; Wang Y; Wang D; Li W; Li C; Gao T; Liu Y; Wang G
    Exp Dermatol; 2011 Jul; 20(7):555-60. PubMed ID: 21355890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dithranol and dimethylfumarate suppress the interferon-gamma-induced up-regulation of cytokeratin 17 as a putative psoriasis autoantigen in vitro.
    Bonnekoh B; Böckelmann R; Ambach A; Gollnick H
    Skin Pharmacol Appl Skin Physiol; 2001; 14(4):217-25. PubMed ID: 11464104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of epidermal expression of keratin K17 in inflammatory skin diseases.
    Komine M; Freedberg IM; Blumenberg M
    J Invest Dermatol; 1996 Oct; 107(4):569-75. PubMed ID: 8823363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGFβ/SMAD/microRNA-486-3p Signaling Axis Mediates Keratin 17 Expression and Keratinocyte Hyperproliferation in Psoriasis.
    Jiang M; Sun Z; Dang E; Li B; Fang H; Li J; Gao L; Zhang K; Wang G
    J Invest Dermatol; 2017 Oct; 137(10):2177-2186. PubMed ID: 28642156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratin 17 in psoriasis: Current understanding and future perspectives.
    Lin Y; Zhang W; Li B; Wang G
    Semin Cell Dev Biol; 2022 Aug; 128():112-119. PubMed ID: 34229948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis.
    Yang L; Jin L; Ke Y; Fan X; Zhang T; Zhang C; Bian H; Wang G
    J Invest Dermatol; 2018 Dec; 138(12):2568-2577. PubMed ID: 29859926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-gamma-dependent in vitro model for the putative keratin 17 autoimmune loop in psoriasis: exploration of pharmaco- and gene-therapeutic effects.
    Bockelmann R; Horn T; Gollnick H; Bonnekoh B
    Skin Pharmacol Physiol; 2005; 18(1):42-54. PubMed ID: 15608502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin 17 as a therapeutic target for the treatment of psoriasis.
    Fu M; Wang G
    J Dermatol Sci; 2012 Sep; 67(3):161-5. PubMed ID: 22795618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms.
    Shi X; Jin L; Dang E; Chang T; Feng Z; Liu Y; Wang G
    J Invest Dermatol; 2011 Dec; 131(12):2401-8. PubMed ID: 21796151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
    Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
    Lovato P; Norsgaard H; Tokura Y; Røpke MA
    J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin 17 covalently binds to alpha-enolase and exacerbates proliferation of keratinocytes in psoriasis.
    Luo Y; Pang B; Hao J; Li Q; Qiao P; Zhang C; Bai Y; Xiao C; Chen J; Zhi D; Liu Y; Dang E; Wang G; Li B
    Int J Biol Sci; 2023; 19(11):3395-3411. PubMed ID: 37497003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-psoriatic properties of paeoniflorin: suppression of the NF-kappaB pathway and Keratin 17.
    Bai X; Yu C; Yang L; Luo Y; Zhi D; Wang G; Dang E
    Eur J Dermatol; 2020 Jun; 30(3):243-250. PubMed ID: 32576538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.